Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1083686

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many patients have been prescribed cannabis-based products for medicinal use; and how many were (a) private prescriptions and (b) prescriptions funded by NHS or NHS Scottish.
tabling member constituency	Kilmarnock and Loudoun
tabling member printed	Alan Brown
uin	229804
answer	answer is ministerial correction date of answer 12/03/2019 answer text <p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019. In Scotland, work is underway to establish similar systems.</p><p> </p><p>There are 95,532 specialist doctors registered on the General Medical Council’s Specialist Register. The law allows any specialist doctor to prescribe cannabis-based products for medicinal use. Specialist doctors may decide to prescribe these products on a case-by-case basis, and where it is clinically appropriate. The Department does not hold information on how many of those practitioners operate private practices and are National Health Service or NHS Scotland employees or where they work.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229805 question first answered 12/03/2019 16:17:58 answering member 4067 label Biography information for Steve Brine
tabling member	4470 label Biography information for Alan Brown

1083687

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many medical practitioners are registered to prescribe cannabis-based products for medicinal use; how many of those practitioners (a) operate private practices and (b) are NHS or NHS Scotland employees; and if he will list the (i) Trusts and (ii) Health boards at which each of those NHS and NHS Scotland employee works.
tabling member constituency	Kilmarnock and Loudoun
tabling member printed	Alan Brown
uin	229805
answer	answer is ministerial correction date of answer 12/03/2019 answer text <p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019. In Scotland, work is underway to establish similar systems.</p><p> </p><p>There are 95,532 specialist doctors registered on the General Medical Council’s Specialist Register. The law allows any specialist doctor to prescribe cannabis-based products for medicinal use. Specialist doctors may decide to prescribe these products on a case-by-case basis, and where it is clinically appropriate. The Department does not hold information on how many of those practitioners operate private practices and are National Health Service or NHS Scotland employees or where they work.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229804 question first answered 12/03/2019 16:17:58 answering member 4067 label Biography information for Steve Brine
tabling member	4470 label Biography information for Alan Brown

1083696

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tomography: Procurement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 March 2019 to Question 227413 on Tomography: Inhealthcare, what the timescale was for the procurement process for PET-CT scanning services in 2017-18.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	229811
answer	answer is ministerial correction date of answer 12/03/2019 answer text <p>The Phase II PET-CT Scanning Services procurement commenced on 10 July 2017 and 10 of the 11 contracts are expected to be awarded in the next four weeks. The exception to this is Lot 4, covering the Thames Valley - Buckinghamshire, Oxfordshire and Berkshire West area, where discussions between the parties involved are still underway.</p><p> </p><p>NHS England has undertaken two phases of procurement for PET-CT services in England, the first completed during 2014-15 and the second is nearing completion. In both cases, NHS England either has or is on-track to secure significantly improved value, both in the form of additional capital investment into new scanners and new scanning locations, and in terms of reduced price to NHS England. As the Phase II process is still underway, it is not possible to make a final assessment of the cost of procurement. However, these will represent a small proportion of the overall forecast benefits.</p><p> </p><p>NHS England undertook a public engagement process between January and February 2016 which was designed to test the phase II procurement approach. The results of this process were incorporated into the final procurement design over the course of 2016/17. A thematic report of the response to public engagement was published in 2017, shortly before the phase II procurement commenced. The report can be found at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2017/04/pet-ct-engagement-report-april-2017.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2017/04/pet-ct-engagement-report-april-2017.pdf</a></p><p> </p><p>NHS England intends to undertake any further required public involvement duties in respect of planned changes in the location of services following completion of the procurement and in accordance with its responsibilities as described in section 13Q of the NHS Act 2006.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229812 229815 question first answered 12/03/2019 16:20:00 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

1083709

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tomography: Procurement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 March 2019 to Question 227413 on Tomography: Inhealthcare, what estimate he has made of the cost to the public purse of the procurement process for PET-CT scanning services in England.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	229812
answer	answer is ministerial correction date of answer 12/03/2019 answer text <p>The Phase II PET-CT Scanning Services procurement commenced on 10 July 2017 and 10 of the 11 contracts are expected to be awarded in the next four weeks. The exception to this is Lot 4, covering the Thames Valley - Buckinghamshire, Oxfordshire and Berkshire West area, where discussions between the parties involved are still underway.</p><p> </p><p>NHS England has undertaken two phases of procurement for PET-CT services in England, the first completed during 2014-15 and the second is nearing completion. In both cases, NHS England either has or is on-track to secure significantly improved value, both in the form of additional capital investment into new scanners and new scanning locations, and in terms of reduced price to NHS England. As the Phase II process is still underway, it is not possible to make a final assessment of the cost of procurement. However, these will represent a small proportion of the overall forecast benefits.</p><p> </p><p>NHS England undertook a public engagement process between January and February 2016 which was designed to test the phase II procurement approach. The results of this process were incorporated into the final procurement design over the course of 2016/17. A thematic report of the response to public engagement was published in 2017, shortly before the phase II procurement commenced. The report can be found at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2017/04/pet-ct-engagement-report-april-2017.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2017/04/pet-ct-engagement-report-april-2017.pdf</a></p><p> </p><p>NHS England intends to undertake any further required public involvement duties in respect of planned changes in the location of services following completion of the procurement and in accordance with its responsibilities as described in section 13Q of the NHS Act 2006.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229811 229815 question first answered 12/03/2019 16:20:01 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

1083724

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tomography: Procurement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 March 2019 to Question 227413 on Tomography: Inhealthcare, for what reasons the procurement process for PET-CT scanning was not subject to public consultation.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	229815
answer	answer is ministerial correction date of answer 12/03/2019 answer text <p>The Phase II PET-CT Scanning Services procurement commenced on 10 July 2017 and 10 of the 11 contracts are expected to be awarded in the next four weeks. The exception to this is Lot 4, covering the Thames Valley - Buckinghamshire, Oxfordshire and Berkshire West area, where discussions between the parties involved are still underway.</p><p> </p><p>NHS England has undertaken two phases of procurement for PET-CT services in England, the first completed during 2014-15 and the second is nearing completion. In both cases, NHS England either has or is on-track to secure significantly improved value, both in the form of additional capital investment into new scanners and new scanning locations, and in terms of reduced price to NHS England. As the Phase II process is still underway, it is not possible to make a final assessment of the cost of procurement. However, these will represent a small proportion of the overall forecast benefits.</p><p> </p><p>NHS England undertook a public engagement process between January and February 2016 which was designed to test the phase II procurement approach. The results of this process were incorporated into the final procurement design over the course of 2016/17. A thematic report of the response to public engagement was published in 2017, shortly before the phase II procurement commenced. The report can be found at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2017/04/pet-ct-engagement-report-april-2017.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2017/04/pet-ct-engagement-report-april-2017.pdf</a></p><p> </p><p>NHS England intends to undertake any further required public involvement duties in respect of planned changes in the location of services following completion of the procurement and in accordance with its responsibilities as described in section 13Q of the NHS Act 2006.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229811 229812 question first answered 12/03/2019 16:20:01 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

1082543

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he will take in the forthcoming workforce implementation plan to ensure that there are sufficient staff in the NHS to diagnose and treat cancer..
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	229138
answer	answer is ministerial correction date of answer 12/03/2019 answer text <p>Health Education England (HEE) published its first ever Cancer Workforce Plan in December 2017. HEE intended to publish a second phase, longer-term strategy that looked at the cancer workforce needs beyond 2021. This work was started and stakeholders from within the National Health Service and the charitable sector contributed to the early discussions. This work has since been superseded by publication of the NHS Long Term Plan in January 2019.</p><p> </p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care has subsequently commissioned Baroness Dido Harding, working closely with Sir David Behan, to lead a number of programmes to engage with key NHS interests to develop a detailed workforce implementation plan. These programmes will consider detailed proposals to grow the workforce rapidly, including staff working on cancer, consider additional staff and skills required, build a supportive working culture in the NHS and ensure first rate leadership for NHS staff.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/03/2019 12:41:00 answering member 4067 label Biography information for Steve Brine
tabling member	3930 label Biography information for Caroline Lucas

1082557

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the proportion of eligible adults who have received (a) abdominal aortic aneurysm, (b) bowel, (c) breast and (d) cervical screening in (i) Lambeth CCG (ii) Southwark CCG and (iii) England in each year since 2015.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	229212
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>Abdominal aortic aneurysm screening coverage for Lambeth Clinical Commissioning Group (CCG), Southwark CCG and England in each year since 2015/16 can be seen in the following table.</p><p> </p><p>Abdominal aortic aneurysm screening coverage for Lambeth CCG, Southwark CCG and England, 2015/16 to 2017/18.</p><table><tbody><tr><td><p> </p></td><td><p>2015/16 % (tested)</p></td><td><p>2016/17 % (tested)</p></td><td><p>2017/18 % (tested)</p></td></tr><tr><td><p>Lambeth CCG</p></td><td><p>61.0 (627)</p></td><td><p>67.5 (664)</p></td><td><p>53.3 (582)</p></td></tr><tr><td><p>Southwark CCG</p></td><td><p>58.8 (550)</p></td><td><p>73.4 (680)</p></td><td><p>45.9 (435)</p></td></tr><tr><td><p>England</p></td><td><p>79.9 (227,442)</p></td><td><p>81.1 (228,441)</p></td><td><p>80.8 (230,543)</p></td></tr></tbody></table><p>Notes:</p><ol><li>Sources:<a href="https://www.gov.uk/government/publications/abdominal-aortic-aneurysm-screening-2015-to-2016-data" target="_blank">https://www.gov.uk/government/publications/abdominal-aortic-aneurysm-screening-2015-to-2016-data</a></li></ol><p> </p><p><a href="https://www.gov.uk/government/publications/abdominal-aortic-aneurysm-screening-2016-to-2017-data" target="_blank">https://www.gov.uk/government/publications/abdominal-aortic-aneurysm-screening-2016-to-2017-data</a></p><p> </p><p><a href="https://www.gov.uk/government/publications/abdominal-aortic-aneurysm-screening-2017-to-2018-data" target="_blank">https://www.gov.uk/government/publications/abdominal-aortic-aneurysm-screening-2017-to-2018-data</a></p><p> </p><ol start="2"><li>Total number of people screened is provided in brackets.</li></ol><p> </p><ol start="3"><li>Coverage is the percentage of the eligible population that is successfully screened within the year plus three months:</li></ol><p> </p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773136/NHS_AAA_screening_programme_standards_data_report_april_2017_to_march_2018.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773136/NHS_AAA_screening_programme_standards_data_report_april_2017_to_march_2018.pdf</a></p><p> </p><p>Bowel cancer screening coverage for Lambeth CCG, Southwark CCG and England is attached. Coverage for bowel cancer screening is defined as the number of persons registered to a general practice who are screened adequately in the previous 30 months, which is the routine period in which bowel cancer screening takes place for an individual, divided by the number of eligible persons on the last day of the review period for this report data is taken in April 2015, 2016, 2017 and 2018. This captures the coverage for the eligible population over the standard period of time in which an individual should attend for a bowel cancer screening.</p><p> </p><p>Breast screening coverage for Lambeth CCG, Southwark CCG and England is attached. Coverage for breast screening is defined as the number of women registered to a general practice screened adequately in the previous 36 months, which is the routine period in which breast screening takes place for an individual, divided by the number of eligible women on last day of the review period for this report data is taken in April 2015, 2016, 2017 and 2018. This captures the coverage for the eligible population over the standard period of time in which a woman should attend for breast screening.</p><p> </p><p>Cervical screening coverage for Lambeth CCG, Southwark CCG and England is attached. Coverage for cervical screening is defined as the number of women screened adequately in the previous 42 months (if aged 24-49) or 66 months (if aged 50-64) divided by the number of eligible women on last day of review period for this report data is taken in April 2015, 2016, 2017 and 2018. This captures the coverage for the eligible population over the standard period of time in which a woman should attend for cervical screening.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/03/2019 18:30:38 answering member 4067 label Biography information for Steve Brine attachment 1 file name PQ229212 attached table.docx title PQ229212 attached table previous answer version 106920 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	4510 label Biography information for Helen Hayes

1082558

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the National Audit Office report entitled Investigation into the management of Health Screening, published 1 February 2019, what steps his Department is taking to ensure NHS screening laboratories are sufficiently staffed.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	229213
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>The National Health Service Long Term Plan sets out specific workforce actions developed by NHS Improvement and others to have positive impact for workforces, including the screening and diagnostic workforce. NHS Improvement and the Department will discuss these actions when the education and training budget for Health Education England is set in 2019. This includes a proposal to recruit an additional 1,500 clinical and diagnostic staff across seven priority specialisms between 2018 and 2021.</p><p> </p><p>With specific reference to the national cervical screening programme that includes NHS laboratories, the replacement of liquid based cytology with human papillomavirus (HPV) testing as the primary screen, has had a significant impact on the ability to maintain staff in the cervical screening programme’s laboratory workforce. The HPV pilot evaluation suggested that the need for a cytology workforce could reduce by as much as 85% when HPV testing is introduced as the primary screen during 2019.</p><p> </p><p>NHS England is undertaking a national procurement process to secure providers of laboratory services to deliver HPV primary screening across England. The outcome of the process will be known by the end of April 2019, with national coverage in place by December 2019.</p><p> </p><p>To maintain the service and accommodate current staffing levels a majority of existing HPV pilot sites and some non-pilot sites have already converted more of their cervical screening activity to HPV primary screening, freeing up cytology capacity.</p><p> </p><p>In addition, Professor Sir Mike Richards is leading a major review of national cancer screening programme pathways as part of the NHS Long Term Plan’s renewed drive to improve care and save lives. Professor Richards’ review is due to report in summer 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/03/2019 18:24:00 answering member 4067 label Biography information for Steve Brine previous answer version 106922 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	4510 label Biography information for Helen Hayes

1082564

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: Labelling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the results of the consultation on mandating calorie labelling in the out-of-home sector will be published.
tabling member constituency	Hove
tabling member printed	Peter Kyle
uin	229218
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>I refer the hon. Member to the answer I gave to the hon. Member for South West Bedfordshire (Andrew Selous MP) on 23 January 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-01-21/210542/" target="_blank">210542</a>.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/03/2019 18:24:52 answering member 4067 label Biography information for Steve Brine previous answer version 106926 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	4505 label Biography information for Peter Kyle

1082590

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tobacco
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 February 2019 to Question 222001, when Public Health England plans to undertake an independent academic review of heated tobacco products.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	229155
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>Under the Government’s Tobacco Control Plan for England, Public Health England (PHE) is committed to conducting an annual review of the evidence on e-cigarettes and other nicotine delivery systems until the end of the Parliament in 2022. This can be viewed at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/towards-a-smoke-free-generation-tobacco-control-plan-for-england" target="_blank">https://www.gov.uk/government/publications/towards-a-smoke-free-generation-tobacco-control-plan-for-england</a></p><p> </p><p>The scope of these reviews includes heated tobacco products and PHE published an evidence review of e-cigarettes and heated tobacco products in February 2018. The review is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/e-cigarettes-and-heated-tobacco-products-evidence-review" target="_blank">https://www.gov.uk/government/publications/e-cigarettes-and-heated-tobacco-products-evidence-review</a></p><p> </p><p>The Government currently has no plans to conduct a separate review of heated tobacco products outside of the programme.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/03/2019 18:31:49 answering member 4067 label Biography information for Steve Brine previous answer version 106923 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	1604 label Biography information for Mr Virendra Sharma